MRSA in hospital intensive care -- what's growing where?March 31, 2008Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today (Monday 31 March 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre. "We are developing a standard sampling regime to take swabs from sinks, taps, floors and other surfaces like computer keyboards, and use these to identify accurately which superbug genes are present in an intensive care unit," says Gemma Kay from Sheffield Hallam University in South Yorkshire. "Critically ill patients in the intensive care unit are particularly at risk from hospital acquired infections." The university research team has been working with clinical collaborators at the Sheffield Teaching Hospitals Trust to develop infection control procedures which could protect vulnerable patients and help to manage any future superbug outbreaks.
"Our technique allows us to characterise the genes from micro-organisms using a gene amplification technique called polymerase chain reaction (PCR). This lets us expand tiny samples enough to identify individual strains of bacteria, and to spot particular antibiotic resistance genes," says Gemma Kay. "Our findings so far, from routine samples taken from the intensive care unit and patients screened over the last 12 months, show extremely low levels of MRSA (methicillin resistant Staphylococcus aureus), known drug resistant bacteria such as Clostridium difficile and other strains of bacteria that can make extended spectrum beta lactamase, which are all resistant to antibiotics commonly used to treat infections," says Gemma Kay. Patients in intensive care units are particularly vulnerable to drug resistant infections, which can worsen their condition, prolong their stay and require heavy antibiotic regimes, diverting significant resources from the hospital budget. To date frequencies of resistant infections in the intensive care unit have been extremely low. "By establishing which organisms and which drug resistance genes are circulating in the intensive care unit we will be able to see to what extent the environment is a potential infection threat to patients," says Gemma Kay. "Our experience so far suggests very good infection control, but the final outcomes of the study may suggest further changes that could provide additional protection for patients." Society for General Microbiology | |||||||||||||||||||||
|
Related MRSA News Articles More severe bone infections, health complications in children linked to MRSA, researchers find The emergence of methicillin-resistant Staphylococcus aureus (MRSA) as a major pathogen has led to more complications and longer hospital stays for children with acute bone infections, UT Southwestern Medical Center researchers report. Overcrowding and understaffing in hospitals increases levels of MRSA infections A review article authored by a University of Queensland academic has found overcrowding and understaffing in hospitals are two key factors in the transmission of MRSA (Meticillin - Resistant Staphylococcus Aureus) infections worldwide. Less hype and more research needed into new 'superbug,' say experts Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the BMJ. Can we 'wipe out' MRSA? Three basic principles is all it could take to reduce the incidence of MRSA in hospitals according to a new research by Cardiff University. Potential treatments from cryptic genes Big pharma gave up on soil bacteria as a source of antibiotics too soon, according to research published in the June issue of Microbiology. Scientists have been mining microbial genomes for new natural products that may have applications in the treatment of MRSA and cancer and have made some exciting discoveries. UV lotion lights the way to cleaner facilities A team of Canadian scientists using a lotion which glows under ultraviolet light have shown that up to a third of patient toilets are not properly cleaned. Superbug genome sequenced The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol. New Clorox disinfectant is EPA registered to kill both known types of MRSA While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers. Turning on cell-cell communication wipes out staph biofilms University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems. Although the discovery is not ready for clinical application, the findings offer insight into a dispersal mechanism for staph biofilms and might help identify therapeutic targets. 'Healing clays' show promise for fighting deadly MRSA superbug infections, other diseases Mud may be coming to a medicine cabinet or pharmacy near you. Scientists in Arizona report that minerals from clay could form the basis of a new generation of inexpensive, highly-effective antimicrobials for fighting MRSA infections that are moving out of health care settings and into the community. More MRSA News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||